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Wednesday, March 9, 2011 549aWe rationally designed, synthesized and tested a novel set of ligands to ex-
ploit a hydrophobic cavity in the vicinity of the docking pose of known li-
gands. All novel ligands showed improved, affinities with respect to their
reference compounds, in good quantitative agreement between experiment
and simulation, some of them reaching nanomolar affinities. Studying a series
of site-specific mutations, we could computationally rationalize the receptor
selectivity of specific compounds to either preferentially bind CB1 or CB2,
respectively.
[1] S.H. Burstein and R.B. Zurier (2009) Cannabinoids, Endocannabinoids, and
Related Analogs in Inflammation,
AAPS J. 11(1), 109-119.
[2] H. Merlitz, B. Burghardt andW. Wenzel (2003) Application of the Stochas-
tic Tunneling Method to High Throughput Database Screening,
Chem. Phys. Lett. 370, 68-73.
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Field-Modulated Magnetic Birefringence Relaxation to Assay b-Adrener-
gic Receptor-Ligand Association
Louis H. Strong, Daniel B. Hall, Hiep-hoa Nguyen, Gyula Varadi.
We developed a platform for monitoring the association between biologically
active molecules and their cognate receptors based on measuring rate changes
of magnetic birefringence relaxation of superparamagnetic nanoparticles. The
method is particularly designed for rapid screening of display libraries and
mutant receptor libraries expressed in bacteria and yeast. The magnitude of
birefringence rate change after particle orientation in a magnetic field reflects
the difference of nanoparticle hydrodynamic volume upon formation of the
‘‘receptor-ligand complex’’. The rationale for using nanoparticle birefrin-
gence to identify ligand and receptor interactions is that it eliminates the
need for removing unbound ligands. We have previously demonstrated that
maghemite nanoparticles, decorated with ligand molecules, exhibit longer re-
laxation times when associated with proteins, viruses and small size microor-
ganisms. We utilize magnetic field-modulated birefringence to monitor
association between a ligand (alprenolol) immobilized on the surface of mag-
netic nanoparticles and b-adrenergic receptor overexpressed on the cell sur-
face of bacteria and yeast. Upon association of the ligand with the
receptor, we observed an increase in the birefringence rate constant, an effect
that was fully reversible by adding b-adrenergic competitor ligands. Rate con-
stant distributions were reconstructed using the Phase Function Method. We
show that birefringence signals can be used to monitor the dynamics of par-
ticle rotational alignment as well as rotational relaxation. Alignment dynam-
ics are characteristic of the number of accessible receptor sites while
relaxation characterizes the aggregate size. This novel approach is applicable
in systems where the interaction of ligand with cognate receptor does not ac-
tivate intracellular pathways and thus are difficult to monitor with a ratio-
fluorometric platform. This method will be useful for a broad range of
applications, including discovery research to develop small molecule drugs
and for identification of orphan receptors and biologically active peptides
and proteins from display libraries.
2985-Pos Board B90
Transient Kinetics of Nucleotide Binding to the P-glycoprotein Multidrug
Transporter
Miguel R. Lugo, Joseph W.K. Chu, Frances J. Sharom.
The P-glycoprotein multidrug transporter (Pgp) is a member of the ABC
(ATP-binding cassette) superfamily of proteins, and contains two highly con-
served cytosolic nucleotide-binding domains (NBDs). These domains couple
ATP hydrolysis to the export of a variety of hydrophobic natural products,
chemotherapeutic drugs and peptides. Pgp ATPase activity has been exten-
sively characterized, but many details of the catalytic cycle of ATP hydro-
lysis remain unexplored. The fluorescent nucleotide analogue, TNP-ADP,
interacts with the NBDs of Pgp, and the stoichiometry and affinity of binding
were previously determined in our laboratory. Transient kinetic methods are
commonly used to investigate the mechanism of molecular processes over
a time-scale from milliseconds to hundreds of seconds. In this work, we
studied the binding of TNP-ADP to Pgp using rapid stopped-flow kinetics.
In these experiments, the binding reaction was monitored by following dif-
ferent fluorescent signals, under pseudo-first-order conditions (excess ligand).
The time course of TNP-ADP binding displayed five relaxation times (ti’s)
over a time-span of 300 sec, which correspond to at least five different tran-
sitions. All the relaxation times presented a strong temperature-dependence.
The time course of the reaction was analyzed by the computational tool
Global Kinetic Explorer (KinTek, USA), using several models of sequential
isomerizations after/before the fast bimolecular binding reaction. Also, theparameters were analyzed using the matrix projection operator technique
for kinetic data (Bujalowski et al., 2000, J. Mol. Biol. 295:831). Both ap-
proaches provide, for the first time, information about the rate constants
and fluorescent properties of the diverse intermediates formed during binding
of TNP-ADP to Pgp. Elucidation of the details of the interaction of nucleo-
tides with Pgp is of prime importance for formulation of a detailed mecha-
nism of action of the transporter.
This research is supported by a grant from the Canadian Cancer Society.
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Identification of an Efficacy Pharmacophore for m Opioid Receptor Li-
gands Using the Conformationally Sampled Pharmacophore (CSP)
Method
Jihyun Shim, Andrew Coop, Alexander D. MacKerell Jr.
m opioid receptor agonists and antagonists play a critical role in the treatment
of severe pain and as treatments for drug abuse. Their structure activity rela-
tionships (SAR) have been extensively investigated followed by lead optimi-
zation. However, challenges remain in improving the utility of m ligands with
respect to reducing adverse effects such as tolerance, dependence, constipa-
tion, etc. while maintaining the potency of current medicines. To facilitate
the meeting of these challenges, consensus pharmacophore models for diverse
classes of m opioid receptor ligands were established and we constructed pre-
dictive model differentiating agonists and antagonists activities using the con-
formationally sampled pharmacophore (CSP) method. The predictability of
the models was validated against a number of classes of opioids including
4,5-Epoxymorphinans, Diels-Alder adducts of thebaine, Benzomorphans,
Methadone, Fentanyl, and, notably, non-nitrogenous opioids; a collection of
compounds which have eluded a consensus SAR of opioids for decades.
The consensus model was derived by virtue of CSP method incorporating
flexibility of molecules through using all-accessible conformers in model de-
velopment and by eliminating any limitations associated with alignment pro-
cedures. The procedures to develop and features of the CSP model will be
presented.
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Probing Binding of Apelin to the Extracellular Loops of the Apelin Recep-
tor (APJ) in Lipid Mimetic Environments
Pascaline Ngweniform, Jan K. Rainey.
a Department of Biochemistry & Molecular Biology and b Department of
Chemistry, Dalhousie University, Halifax, NS B3H 1X5.
The apelin receptor, previously called APJ, is a G protein-coupled receptor
highly expressed in the central nervous system (CNS), cardiovascular system,
the adipoinsular axis and the mammary glands, among other tissues and organ
systems. The apelinergic system plays important biological functions in the
regulation of blood pressure, blood glucose, drinking behavior and food intake.
The action of this system is also implicated in tumour angiogenesis, diabetes
and cardiovascular diseases. In addition, the apelin receptor is a co-receptor
for human immunodeficiency virus type 1 (HIV1) and simian immunodefi-
ciency virus (SIV). Despite these roles, the mechanism of activation of apelin
receptor by its cognate ligand has not been studied at the molecular level. Fol-
lowing the ‘‘divide and conquer’’ approach for membrane protein characteriza-
tion, we present the biophysical characterization of the interaction of two
extracellular loops of the apelin receptor (extracellular loops 1, EL1 and 3,
EL3) with a fluorescently-tagged apelin analogue in lipid environment. Pep-
tides were synthesized by solid phase peptide synthesis and purified by high-
performance liquid chromatography. Characterization both of the peptides in
isolation and of the binding between apelin and EL peptides is provided using
circular dichroism spectroscopy, fluorescence resonance energy transfer and
nuclear magnetic resonance spectroscopy. These results provide insight into
understanding of the apelinergic system at the molecular level and provide
the first structural information on the apelin receptor for the development of
therapeutics targeting this system.
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Design and Biophysical Characterization of a Single Chain Four-alpha-
helix Bundle Protein Which Binds Volatile General Anesthetics
Lucia M. Morstadt, Qing Cheng Meng, Jonas S. Johansson.
In order to investigate the interaction of volatile general anesthetics with their
putative membrane protein targets, we designed a four-alpha-helix bundle
protein in a single protein chain. The four alpha helices, connected by three
8 glycine loops, had the sequence A, B, B’, A’. The DNA sequence was de-
signed with the goal of making helices with the same amino acid sequence
(helix A and A’, B and B’, respectively) as different as possible in their
550a Wednesday, March 9, 2011DNA sequence, while using codons which are favorable for expression in
E.coli. Restriction enzyme sites were added on both ends. The synthesized
DNA sequence was cloned into an expression vector. The protein was bacte-
rially expressed and purified to homogeneity using reverse-phase HPLC. Pro-
tein identity was verified using MALDI-TOF mass spectroscopy. Near UV
circular dichroism spectroscopy confirmed the strongly alpha helical nature
of the protein. Guanidinuium chloride denaturation showed that the single
chain four-alpha-helix bundle protein is twice as stable as the dimeric di-
helical protein. The sigmoidal character of the unfolding reaction was con-
served, the sharpness of the transition increased. Our single chain four-
alpha-helix bundle protein bound halothane with a dissociation constant of
1.2 mM, as shown by tryptophan fluorescence quenching. This single chain
four-alpha-helix bundle protein can now be used as a scaffold to incorporate
natural membrane protein sequences to examine general anesthetic interac-
tions in detail.
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Binding Profiles Based on Normal Mode Analysis as a Foundation for
a Unified Approach to Allosteric Activation of Prolactin Receptor
Adam D. Schuyler.
Two of the most fundamental biological processes are ligand binding and al-
losteric signaling. Despite their (often) direct linkage, a unified model of the
underlying dynamics is not well established. The harmonic motions identified
by normal mode analysis (NMA) provide a natural coordinate system for con-
formation space. Binding profiles and allosteric profiles based on NMA allow
for a unified model which describes the propensity for various structure mo-
tions to promote/inhibit binding and allosteric activation. The authors have re-
cently developed the allosteric model; the current work presents the binding
model.
The normal modes describe local motions accessible to a conformation. Each of
the modes is followed over a small displacement, leading to a set of new con-
formations. This procedure is repeated to generate an ensemble, where each
conformation is defined by its sequence of normal modes. Ensembles are gen-
erated around a receptor and ligand. Each receptor conformation is paired
against each ligand conformation and scored for: (1) compatibility of interface
shape; and (2) compatibility of interface dynamics. These scores are attributed
to the normal mode sequences associated with each candidate conformation.
The scores are summed over all possible conformation pairings, producing
a binding profile that defines each normal mode’s propensity to contribute to
compatible interface shape and interface dynamics.
The prolactin receptor dimerizes and preferentially binds prolactin at one bind-
ing site, and then binds another prolactin at the second binding site - activating
the receptor. Binding profiles are generated for prolactin and prolactin receptor,
isolated from the various complexes along the activation pathway. The goal is
to identify the dynamics that regulate binding site preference and allosteric ac-
tivation. Future work will incorporate NMR studies to validate and refine the
initial results.
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Solid-State NMR Study of Ligand Binding to Human Peripheral Cannabi-
noid Receptor CB2
Tomohiro Kimura, Alexei Yeliseev, Mihaela Mihailescu, Kejun Cheng,
Kenner C. Rice, Klaus Gawrisch.
The peripheral cannabinoid receptor CB2 belongs to the family of G protein
coupled receptors (GPCRs). Ligand binding studies on CB2 are complicated
by high affinity of the endogenous or exogenous cannabinoid ligands for the
lipid matrix that hosts the GPCR. Here we show that solid-state NMR distin-
guishes between specific ligand-binding to CB2 and nonspecific interactions
with the lipid matrix. Experiments were conducted with recombinant, human
CB2 expressed in E. coli, purified and functionally reconstituted into unila-
mellar liposomes. Location, structure, and dynamics of ligands in the lipid
matrix were probed by NMR as well as neutron diffraction. The synthetic ag-
onist CP-55,940 locates near the hydrophobic/hydrophilic interface of bilayers
with its bond linking hydroxyphenyl and hydroxycyclohexyl rings perpendic-
ular to the bilayer normal, while the endogenous agonist 2-AG orients parallel
to the bilayer normal with the glycerol moiety near the hydrophobic/hydro-
philic interface and the arachidonoyl chain in the hydrophobic region. Both
ligands maintain a high level of conformational flexibility and have lateral
diffusion rates in membranes comparable to those of lipids. Ligand binding
to CB2 drastically shortens transverse relaxation times of the 2H-labeled li-
gands which distinguish between specific and non-specific binding events.
Competition binding experiments with protonated and selectively deuterated
CP-55,940 showed that ~90% of the reconstituted CB2 was ligand-bindingcompetent and formed a one-to-one complex with the ligand. Activation of
G protein by agonist-bound CB2 was confirmed in a G protein activation as-
say. The endogenous 2-AG has a binding affinity to CB2 that is orders of
magnitude lower compared to CP-55,940. The possibility that cannabinoid li-
gands approach the receptor from the lipid matrix will be discussed. Experi-
ments are underway to gain structural insights into specific binding
interactions based on selective isotope-labeling of both ligand and recombi-
nant CB2.
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Fluorescence Guided Force Microscopy (FGFM) Used to Measure Recep-
tor Ligand Interactions in Live Mammalian Cells
Jeremy C. Bonor.
Fluorescence Guided Force Microscopy (FGFM) is a new technique that was
developed in order to measure and quantify ligand surface interactions on the
cell surface in living cells. Using this method we can determine the binding af-
finity of ligands with surface receptors and their spatial distribution by combin-
ing force volume measurements, confocal microscopy and atomic force
microscopy into one new instrumental setup. In order to validate this new
method we covalently linked a ligand, Bone Morphogenetic Protein 2
(BMP2) to an Atom Force Microscopy (AFM) probe and acquired topograph-
ical and force binding information. To visualize caveolae by confocal micros-
copy, membrane domains known to co-localize with BMP receptors on the cell
surface, Caveolin-1 was fused to green or red fluorescent protein and used as
a marker. We transfected C2C12 cells with plasmids encoding Caveolin-1 iso-
forms alpha and beta (fused to green fluorescent protein) and Caveolin-1 alpha
(fused to red fluorescent protein). Detecting the unbinding forces, surface to-
pography and fluorescent protein location on the live cell surface, required
combining Force Volume measurements, AFM and confocal imaging; which
we achieved through the integration of the Veeco Bioscope2 AFM module,
equipped with a closed loop scanner and a Zeiss LSM510 NLO confocal.
The collection of high resolution confocal images, AFM images and unbinding
force curve data on live cells allowed us to resolve the spatial distribution of
binding events on the plasma membrane of C2C12 cells. This data showed
that BMP 2 bound with the highest affinity inside Caveolin-1 isoforms.
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Nanoparticles Masquerade as ‘‘Self’’ to Inhibit Phagocytosis
Pia L. Rodriguez, Takamasa Harada, Dennis E. Discher.
A major challenge for injecting particles or implanting biomaterials into the
body is that they activate immune cells such as macrophages, the cells that
normally function to clear invading pathogens. Interestingly, macrophages
have a surface receptor mechanism which prevents them from phagocytosing
our own ‘‘self’’ cells. During initial macrophage engulfment, macrophages
recognize foreign and self targets because they both have antibodies or
plasma complement proteins on their surface. However, before the macro-
phage engulfs the target, self cells are checked for the presence of the surface
protein CD47 which will bind to the macrophage receptor SIRPa (CD172),
and we show that CD47-SIRPa interactions in cell-cell adhesion, with human
macrophages in sparse culture, produce phagocytosis inhibition. Whether the
CD47 interaction is functional with small targets of phagocytosis is unclear
and relevant perhaps to nano-sized targets. We show that CD47 coupled to
a series of synthetic beads can inhibit uptake by macrophages. However,
we need to test this interaction and observe how these results are consistent
with in vivo systems. We are currently testing whether nanoparticles that
have surface immobilized hCD47 or a portion of it will not be phagocytosed
in nobese diabetic (NOD) mice, we believe that hCD47 will bind to this
mSirpa strain and that could bring a better understanding of the interaction
at a nanoscale.
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In Vivo Binding Kinetics and Stoichiometry of Toll-Like Receptor 9 and
CpG DNA Resolved by Multiparametric Single Molecule Techniques
Jiji Chen, Suman Nag, Joseph Irudayaraj.
Toll-like receptor 9 (TLR9) activates the innate immune system in response
to oligonucleotides rich in CpG whereas DNA lacking CpG could inhibit its
activation. Although in vitro experiments demonstrate TLR9 binding to nu-
cleic acids, the mechanism of how this receptor interacts with nucleic acid
and becomes activated in live cells is far from behind understood. Here,
we report on the successful implementation of single molecule tools, consti-
tuting fluorescence correlation spectroscopy (FCS), fluorescence cross-
correlation spectroscopy (FCCS), photon count histogram (PCH) and fluores-
cence lifetime imaging (FLIM) to study the interaction of TLR9-GFP with
Cy5 labeled oligonucleotide containing CpG or lacking CpG in live cells.
